tiprankstipranks
Trending News
More News >
Astellas Pharma Inc (JP:4503)
:4503
Japanese Market

Astellas Pharma (4503) Financial Statements

Compare
3 Followers

Astellas Pharma Financial Overview

Astellas Pharma's market cap is currently $2.46T. The company's EPS TTM is ¥41.84; its P/E ratio is 47.31; and it has a dividend yield of 5.26%. Astellas Pharma is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is ¥19.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 1.91T¥ 1.60T¥ 1.52T¥ 1.30T¥ 1.25T
Gross Profit¥ 1.43T¥ 1.31T¥ 1.23T¥ 1.04T¥ 1.00T
Operating Income¥ 255.67B¥ 124.61B¥ 133.03B¥ 155.69B¥ 136.05B
EBITDA¥ 248.30B¥ 195.34B¥ 240.46B¥ 241.03B¥ 219.83B
Net Income¥ 50.75B¥ 17.05B¥ 98.71B¥ 124.09B¥ 120.59B
Balance Sheet
Cash & Short-Term Investments¥ 188.37B¥ 335.69B¥ 396.62B¥ 337.28B¥ 331.69B
Total Assets¥ 3.34T¥ 3.57T¥ 2.46T¥ 2.33T¥ 2.27T
Total Debt¥ 831.43B¥ 1.01T¥ 200.01B¥ 212.74B¥ 278.26B
Net Debt¥ 643.05B¥ 670.03B¥ -176.83B¥ -103.24B¥ -47.86B
Total Liabilities¥ 1.83T¥ 1.97T¥ 948.56B¥ 872.09B¥ 887.51B
Stockholders' Equity¥ 1.51T¥ 1.60T¥ 1.51T¥ 1.46T¥ 1.39T
Cash Flow
Free Cash Flow¥ 164.61B¥ 89.98B¥ 239.23B¥ 181.00B¥ 229.40B
Operating Cash Flow¥ 201.61B¥ 172.47B¥ 327.77B¥ 257.44B¥ 306.84B
Investing Cash Flow¥ -96.52B¥ -845.80B¥ -84.50B¥ -62.41B¥ -81.89B
Financing Cash Flow¥ -261.37B¥ 614.06B¥ -195.62B¥ -216.30B¥ -229.48B
Currency in JPY

Astellas Pharma Earnings and Revenue History

Astellas Pharma Debt to Assets

Astellas Pharma Cash Flow

Astellas Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis